TWST
Twist Bioscience Corp

3,943
Loading...
Loading...
News
all
press releases
Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience
Biotech stocks gain momentum as M&A, AI-driven drug discovery, and new approvals fuel growth; Halozyme, Akero, Kiniska, ANI and Twist stand out.
Zacks·4d ago
News Placeholder
More News
News Placeholder
5 Biotech Stocks Worth Adding to Your Portfolio Now
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, AKRO, KSNA, ANIP and TWST in this volatile sector
Zacks·4d ago
News Placeholder
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.
Zacks·9d ago
News Placeholder
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)
The heavy selling pressure might have exhausted for Twist Bioscience (TWST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·2mo ago
News Placeholder
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will...
Business Wire·7mo ago
News Placeholder
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (Twist or the Company), a core mid-cap growth and value equity company in the life sciences segment of...
Business Wire·7mo ago
News Placeholder
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business...
Business Wire·8mo ago
News Placeholder
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Emily M. Leproust, Ph.D., CEO...
Business Wire·9mo ago
News Placeholder
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care PR...
PR Newswire·10mo ago

Latest TWST News

View

Advertisement|Remove ads.

Advertisement|Remove ads.